Research ArticleOriginal Research

Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use

Melissa C. Norton, Meghan E. Haftman and Lyndsey N. Buzzard
The Journal of the American Board of Family Medicine September 2020, 33 (5) 745-753; DOI: https://doi.org/10.3122/jabfm.2020.05.200044

References

  1. 1.↵
    1. Hazen ACM,
    2. de Bont AA,
    3. Boelman L,
    4. et al
    . The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: A systematic review. Res Social Adm Pharm 2018;14:228–40.
    OpenUrl
  2. 2.↵
    1. Chua SS,
    2. Kok LC,
    3. Yusof FAM,
    4. et al
    . Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension, or hyperlipideamia in primary care settings. BMC Health Serv Res 2012;12:388.
    OpenUrlPubMed
  3. 3.↵
    1. Jun JK
    . The role of pharmacy through collaborative practice in an ambulatory care clinic. Am J Lifestyle Med 2019;13:275–81.
    OpenUrl
  4. 4.↵
    1. Chisholm-Burns MA,
    2. Kim Lee J,
    3. Spivey CA,
    4. et al
    . US pharmacists' effect as team members on patient care: systematic review and meta-analysis. Med Care 2010;48:923–33.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Giberson S,
    2. Yoder S,
    3. Lee MP
    . Improving patient and health system outcomes through advanced pharmacy practice. A Report to the U.S. Surgeon General. Office of the Chief Pharmacist. Washington, DC: U.S. Public Health Service. 2011.
  6. 6.↵
    1. Brunisholz KD,
    2. Olson J,
    3. Anderson JW,
    4. et al
    . “Pharming out” support: a promising approach to integrating clinical pharmacists into established primary care medical home practices. J Int Med Res 2018;46:234–48.
    OpenUrl
  7. 7.↵
    1. Dixon DL,
    2. Sisson EM,
    3. Parod ED,
    4. et al
    . Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population. J Clin Hypertens 2018;20:88–95.
    OpenUrl
  8. 8.↵
    1. Boykin A,
    2. Wright D,
    3. Stevens L,
    4. et al
    . Interprofessional care collaboration for patients with heart failure. Am J Health Syst Pharm 2018;75:e45–e49.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Nagelkerk J,
    2. Thompson ME,
    3. Bouthillier M,
    4. et al
    . Improving outcomes in adults with diabetes through an interprofessional collaborative practice program. J Interprof Care 2018;32:4–13.
    OpenUrl
  10. 10.↵
    1. Schwartz EJ,
    2. Turgeon J,
    3. Patel J,
    4. et al
    . Implementation of a standardized medication therapy management plus approach within primary care. J Am Board Fam Med 2017;30:701–14.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Cox N,
    2. Tak CR,
    3. Cochella SE,
    4. et al
    . Impact of pharmacist previsit input to provider on chronic opioid prescribing safety. J Am Board Fam Med 2018;31:105–12.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Jones LK,
    2. Greskovic G,
    3. Grassi DM,
    4. et al
    . Medication therapy disease management: Geisinger's approach to population health management. Am J Health-Syst Pharm 2017;74:1422–35.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Gums TH,
    2. Carter BL,
    3. Milavetz G,
    4. et al
    . Physician–pharmacist collaborative management of asthma in primary care. Pharmacotherapy 2014;34:1033–42.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Centers for Disease Control and Prevention. Advancing team-based care through collaborative practice agreements: a resource and implementation guide for adding pharmacists to the care team. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
  15. 15.↵
    1. Weaver K,
    2. Brookhart A,
    3. Kent J,
    4. et al
    . The team approach to health care. J Am Pharm Assoc 2016;56:616–9.
    OpenUrl
  16. 16.↵
    1. Pontefract BA,
    2. King BS,
    3. Gothard DM,
    4. et al
    . Impact of pharmacist-led diabetes management in primary care clinics. Innov Pharm 2018;9:17–8.
    OpenUrl
  17. 17.↵
    1. Matzke GR,
    2. Moczygemba LR,
    3. Williams KJ,
    4. et al
    . Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization. Am J Health Syst Pharm 2018;75:1039–47.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Wubben DP,
    2. Vivian EM
    . Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008;28:421–36.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Ip EJ,
    2. Shah BM,
    3. Yu J,
    4. et al
    . Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health Syst Pharm 2013;877–86.
  20. 20.↵
    1. Hirsch JD,
    2. Steers N,
    3. Adler DS,
    4. et al
    . Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther 2014;36:1244–54.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Funk KA,
    2. Pestka DL,
    3. Roth McClurg MT,
    4. et al
    . Primary care providers believe that comprehensive medication management improves their work-life. J Am Board Fam Med 2019;32:462–73.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Kulchaitanaroaj P,
    2. Brooks JM,
    3. Chaiyakunapruk N,
    4. et al
    . Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens 2017;35:178–87.
    OpenUrl
  23. 23.↵
    1. Sease JM,
    2. Franklin MA,
    3. Gerrald KR
    . Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic. Am J Health-Syst Pharm 2013;70:43–7.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Schultz JL,
    2. Horner KE,
    3. McDanel DL,
    4. et al
    . Comparing clinical outcomes of a pharmacist-managed diabetes clinic to usual physician-based care. J Pharm Pract 2018;31:268–71.
    OpenUrl
  25. 25.↵
    1. Santschi V,
    2. Chiolero A,
    3. Paradis G,
    4. et al
    . Pharmacist interventions to improve cardiovascular disease risk factors in diabetes. Diabetes Care 2012;35:2706–17.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Stratton IM,
    2. Adler AI,
    3. Neil HA,
    4. et al
    . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    National Committee for Quality Assurance. Comprehensive diabetes care (CDC 2019). www.ncqa.org/hedis/measures/comprehensive-diabetes-care. Accessed December 23, 2019.
  28. 28.↵
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2019;42:S61–S70.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Schroeder SA,
    2. Frist W
    . Phasing out fee-for-service payment. N Engl J Med 2013;368:2029–32.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Bazemore A,
    2. Phillips RL,
    3. Glazier R,
    4. Tepper J
    . Advancing primary care through alternative payment models: lessons from the United States and Canada. J Am Board Fam Med 2018;31:322–7.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords